FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204548441> ?p ?o ?g. }

• W3204548441 abstract "As the society is aging, the increasing prevalence of osteoporosis has generated huge social and economic impact, while the drug therapy for osteoporosis is limited due to multiple targets involved in this disease. Zhuangguguanjie formulation (ZG) is extensively used in the clinical treatment of bone and joint diseases, but the underlying mechanism has not been fully described. This study aimed to examine the therapeutic effect and potential mechanism of ZG on postmenopausal osteoporosis. The ovariectomized (OVX) mice were treated with normal saline or ZG for 4 weeks after ovariectomy following a series of analyses. The bone mass density (BMD) and trabecular parameters were examined by micro-CT. Bone remodeling was evaluated by the bone histomorphometry analysis and ELISA assay of bone turnover biomarkers in serum. The possible drug-disease common targets were analyzed by network pharmacology. To predict the potential biological processes and related pathways, GO/KEGG enrichment analysis was performed. The effects of ZG on the differentiation phenotype of osteoclasts and osteoblasts and the predicted pathway were verified in vitro. The results showed that ZG significantly improved the bone mass and micro-trabecular architecture in OVX mice compared with untreated OVX mice. ZG could promote bone formation and inhibit bone resorption to ameliorate ovariectomy-induced osteoporosis as evidenced by increased number of osteoblast (N.Ob/Tb.Pm) and decreased number of osteoclast (N.Oc/Tb.Pm) in treated group compared with untreated OVX mice. After identifying potential drug-disease common targets by network pharmacology, GO enrichment analysis predicted that ZG might affect various biological processes including osteoblastic differentiation and osteoclast differentiation. The KEGG enrichment analysis suggested that PI3K/Akt and mTOR signaling pathways could be the possible pathways. Furthermore, the experiments in vitro validated our findings. ZG significantly down-regulated the expression of osteoclast differentiation markers, reduced osteoclastic resorption, and inhibited the phosphorylation of PI3K/Akt, while ZG obviously up-regulated the expression of osteogenic biomarkers, promoted the formation of calcium nodules, and hampered the phosphorylation of 70S6K1/mTOR, which can be reversed by the corresponding pathway activator. Thus, our study suggested that ZG could inhibit the PI3K/Akt signaling pathway to reduce osteoclastic bone resorption as well as hamper the mTORC1/S6K1 signaling pathway to promote osteoblastic bone formation." @default.
• W3204548441 created "2021-10-11" @default.
• W3204548441 creator A5007557644 @default.
• W3204548441 creator A5024091383 @default.
• W3204548441 creator A5027381024 @default.
• W3204548441 creator A5044604535 @default.
• W3204548441 creator A5046202808 @default.
• W3204548441 creator A5049981926 @default.
• W3204548441 creator A5068873274 @default.
• W3204548441 creator A5080047229 @default.
• W3204548441 creator A5081067856 @default.
• W3204548441 date "2021-10-01" @default.
• W3204548441 modified "2023-10-07" @default.
• W3204548441 title "Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation" @default.
• W3204548441 cites W1013158645 @default.
• W3204548441 cites W1574748094 @default.
• W3204548441 cites W2006950202 @default.
• W3204548441 cites W2045604110 @default.
• W3204548441 cites W2062673020 @default.
• W3204548441 cites W2121836743 @default.
• W3204548441 cites W2144398259 @default.
• W3204548441 cites W2156267537 @default.
• W3204548441 cites W2268193501 @default.
• W3204548441 cites W2328029390 @default.
• W3204548441 cites W2369391196 @default.
• W3204548441 cites W2437593330 @default.
• W3204548441 cites W2713210942 @default.
• W3204548441 cites W2731856918 @default.
• W3204548441 cites W2732630371 @default.
• W3204548441 cites W2886799280 @default.
• W3204548441 cites W2903038722 @default.
• W3204548441 cites W2905213313 @default.
• W3204548441 cites W2916484820 @default.
• W3204548441 cites W2951335495 @default.
• W3204548441 cites W2973788741 @default.
• W3204548441 cites W2984955289 @default.
• W3204548441 cites W2990451375 @default.
• W3204548441 cites W2995446227 @default.
• W3204548441 cites W2999421965 @default.
• W3204548441 cites W3005722875 @default.
• W3204548441 cites W3097231047 @default.
• W3204548441 cites W3121504546 @default.
• W3204548441 cites W3122870545 @default.
• W3204548441 cites W3164477084 @default.
• W3204548441 cites W4210657902 @default.
• W3204548441 cites W4239411780 @default.
• W3204548441 cites W3001698607 @default.
• W3204548441 doi "https://doi.org/10.3389/fphar.2021.727808" @default.
• W3204548441 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8517248" @default.
• W3204548441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34658868" @default.
• W3204548441 hasPublicationYear "2021" @default.
• W3204548441 type Work @default.
• W3204548441 sameAs 3204548441 @default.
• W3204548441 citedByCount "0" @default.
• W3204548441 crossrefType "journal-article" @default.
• W3204548441 hasAuthorship W3204548441A5007557644 @default.
• W3204548441 hasAuthorship W3204548441A5024091383 @default.
• W3204548441 hasAuthorship W3204548441A5027381024 @default.
• W3204548441 hasAuthorship W3204548441A5044604535 @default.
• W3204548441 hasAuthorship W3204548441A5046202808 @default.
• W3204548441 hasAuthorship W3204548441A5049981926 @default.
• W3204548441 hasAuthorship W3204548441A5068873274 @default.
• W3204548441 hasAuthorship W3204548441A5080047229 @default.
• W3204548441 hasAuthorship W3204548441A5081067856 @default.
• W3204548441 hasBestOaLocation W32045484411 @default.
• W3204548441 hasConcept C111472728 @default.
• W3204548441 hasConcept C126322002 @default.
• W3204548441 hasConcept C134018914 @default.
• W3204548441 hasConcept C138885662 @default.
• W3204548441 hasConcept C170033053 @default.
• W3204548441 hasConcept C170493617 @default.
• W3204548441 hasConcept C185592680 @default.
• W3204548441 hasConcept C202751555 @default.
• W3204548441 hasConcept C2776033226 @default.
• W3204548441 hasConcept C2776169692 @default.
• W3204548441 hasConcept C2776541429 @default.
• W3204548441 hasConcept C2777164284 @default.
• W3204548441 hasConcept C2778260815 @default.
• W3204548441 hasConcept C2779134260 @default.
• W3204548441 hasConcept C2779240191 @default.
• W3204548441 hasConcept C2780035454 @default.
• W3204548441 hasConcept C55493867 @default.
• W3204548441 hasConcept C673006 @default.
• W3204548441 hasConcept C71924100 @default.
• W3204548441 hasConcept C8264082 @default.
• W3204548441 hasConcept C89611455 @default.
• W3204548441 hasConcept C98274493 @default.
• W3204548441 hasConceptScore W3204548441C111472728 @default.
• W3204548441 hasConceptScore W3204548441C126322002 @default.
• W3204548441 hasConceptScore W3204548441C134018914 @default.
• W3204548441 hasConceptScore W3204548441C138885662 @default.
• W3204548441 hasConceptScore W3204548441C170033053 @default.
• W3204548441 hasConceptScore W3204548441C170493617 @default.
• W3204548441 hasConceptScore W3204548441C185592680 @default.
• W3204548441 hasConceptScore W3204548441C202751555 @default.
• W3204548441 hasConceptScore W3204548441C2776033226 @default.
• W3204548441 hasConceptScore W3204548441C2776169692 @default.
• W3204548441 hasConceptScore W3204548441C2776541429 @default.
• W3204548441 hasConceptScore W3204548441C2777164284 @default.
• W3204548441 hasConceptScore W3204548441C2778260815 @default.

• next